Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009

"We were pleased to report a particularly strong quarter for product sales, which was driven by the continued strong performance of our Proprietary Medical Products, where we saw sales growth of 53% compared to the same period in 2008," said Dr. William Hunter, President and CEO of Angiotech. "We are particularly pleased by the continued success of our Quill(TM) SRS product line, which we believe will continue to be a strong performer during 2010."

    Fourth Quarter Financial Highlights

    -   Total revenue was $63.6 million.

    -   Net product sales were $50.0 million. Sales of our Proprietary
        Medical Products were $18.3 million, or 37% of total product sales.
        Sales of our Base Medical Products were $31.7 million, or 63% of
        total product sales.

    -   Royalty revenue was $13.5 million.

    -   Research and development expenses were $6.2 million.

    -   Selling, general and administrative expenses were $22.4 million.

    -   Net loss and net loss per share were $15.6 million and $0.18,

    -   As of December 31, 2009, cash and short-term investments were
        $57.3 million and net debt was $517.7 million.

    Selected Non-GAAP Financial Measures

    -   Certain financial measures in this press release are prepared in
        accordance with United States Generally Accepted Accounting
        Principles ("GAAP"). In addition, certain financial measures
        presented below and in the appendix to this press release are non-
        GAAP, or adjusted, financial measures that exclude certain items.
        Management uses certain non-GAAP, or adjusted, financial measures to
        establish operational goals, and believes that these measures may
        assist investors in evaluating the results of our business and
        analyzing the underlying trends in our business over time. Investors
        should consider these non-GAAP adjusted financial measures in
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
(Date:9/22/2014)... researchers at the USC Viterbi School of Engineering, ... microfluidic system quickly and cheaply by simply snapping ... systems are used in many fields including engineering, ... of fluids for use in applications such as ... testing, and synthetic chemistry. Traditionally, microfluidic devices are ...
(Date:9/22/2014)... in a mouse model of pancreatic cancer identified distinct ... including significant differences from the primary tumor that may ... their study reported in the Sept. 25 issue of ... Hospital (MGH) Cancer Center identified several different classes of ... to be targets for improved treatment of the deadly ...
(Date:9/22/2014)... researchers have developed a unique nanoscale device that ... light. The discovery could have major implications for ... computation and communication. , The research paper by ... professor Mo Li and his graduate student Huan ... in the October issue of Nature Nanotechnology ...
(Date:9/22/2014)... September 22, 2014 Lawrence Livermore ... John DeGioia on Friday renewed their institutional commitment ... additional five years to expand the collaborative work ... and global climate, energy and environmental sciences. , ... MOU originally signed in December 2009 and is ...
Breaking Biology Technology:Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 2Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 3Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 4Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 5Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3Engineers show light can play seesaw at the nanoscale 2Lawrence Livermore Renews Pact with Georgetown University to Expand Research and Education in Science and Policy 2
... - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ... investment in British Canadian Biosciences Corp. (BCBC), a privately ... for the treatment of a variety of conditions, including ... preferred shares of BCBC in exchange for 200,000 common ...
... The Case Western Reserve University Biomedical Engineering Department ... benefiting newborns and the aged, the critically ill and ... the future as it celebrates its 40th anniversary, Thursday, ... first universities in the nation to offer graduate and ...
... HARRISBURG, Pa., Oct. 20 PresentCare, a technology ... AdherencePlus(TM) solution, an innovative approach to assist the ... medication non-adherence. The AdherencePlus solution is comprised ... communication technology combined with unprecedented human touch. Both ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company 240 Years on the Leading Edge: Case Western Reserve University's Biomedical Engineering Department Commemorates Achievement, Looks to Future 2Medication Adherence Technology Combines with Patient Outreach Program to Yield Healthier Populations and Reduce Healthcare Costs 2Medication Adherence Technology Combines with Patient Outreach Program to Yield Healthier Populations and Reduce Healthcare Costs 3
(Date:9/22/2014)... A new American Cancer Society study suggests that ... previously known as the food stamp program, had ... non-participants. The authors say the findings emphasize the ... dietary quality of SNAP participants. , The SNAP ... with the resources to obtain a nutritionally adequate ...
(Date:9/22/2014)... researchers are studying a potential new treatment that reverses ... which scars develop in the lungs and severely hamper ... which is delivered to lung tissue intravenously. In mouse ... fibrosis after several days. , The findings were ... Medicine . , "The mimic, when injected into the ...
(Date:9/22/2014)... As genetic sequencing technologies continue to evolve rapidly, becoming ... to establish appropriate policies and regulatory frameworks to address ... special policy issue of the Journal of Law, ... by experts with the Center for Medical Ethics and ... makers the tools to jumpstart this process. , ...
Breaking Biology News(10 mins):Federal food program puts food on the table, but dietary quality could be improved 2Reversing the effects of pulmonary fibrosis 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3
... by suppressing one of the genes that normally switches on ... This has major implications not just for wound victims but ... or abdominal surgery. When skin is damaged a blood ... the damage, leading to scarring. Scarring is a natural part ...
... French and German . ... EPFL in Switzerland have developed a novel method for ... medical and industrial imaging equipment. Dark-field images provide ... used to diagnose the onset of osteoporosis, breast cancer ...
... is available in French . , A ... small differences between individuals at the DNA level can ... proteins. These, in turn, are responsible for the vast ... study, part of the Genome Regulators in Disease (GRID) ...
Cached Biology News:Skin care: new research into scar-free healing 2New technology sharpens X-ray vision 2Tiny genetic differences have huge consequences: McGill researchers 2
Denhardt's powder mixture (for 50X stock solution)...
... SYBR Green Mixes are optimised for SYBR Green ... to perform Quantitative PCR, with the exception of ... Mix contains optimal levels of active SYBR Green ... a proprietary reaction buffer that enables detection of ...
... Roto-Shake Genie is an all-in-one rotator/rocker ... performs five different mixing motions: ... as well as a combination of ... moving portion of the Vibraotme Roto-Shake ...
Biology Products: